WO2008052861A3 - Verfahren zur herstellung von 1,3 -hetero-aromatischen carbonaten - Google Patents

Verfahren zur herstellung von 1,3 -hetero-aromatischen carbonaten Download PDF

Info

Publication number
WO2008052861A3
WO2008052861A3 PCT/EP2007/060676 EP2007060676W WO2008052861A3 WO 2008052861 A3 WO2008052861 A3 WO 2008052861A3 EP 2007060676 W EP2007060676 W EP 2007060676W WO 2008052861 A3 WO2008052861 A3 WO 2008052861A3
Authority
WO
WIPO (PCT)
Prior art keywords
heteroaromatic
producing
carbonates
formula
r2oco2
Prior art date
Application number
PCT/EP2007/060676
Other languages
English (en)
French (fr)
Other versions
WO2008052861A2 (de
Inventor
Roland Kalb
Original Assignee
Proionic Production Of Ionic S
Roland Kalb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proionic Production Of Ionic S, Roland Kalb filed Critical Proionic Production Of Ionic S
Publication of WO2008052861A2 publication Critical patent/WO2008052861A2/de
Publication of WO2008052861A3 publication Critical patent/WO2008052861A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Die Erfindung betrifft ein Verfahren zur Herstellung 1,3-heteroaromatischer Alkylcarbonate der Formel [A]+ [R2OCO2]- (I), in der [A]+ für eine Formel (IIa) oder (IIb) steht.
PCT/EP2007/060676 2006-10-10 2007-10-09 Verfahren zur herstellung von 1,3 -hetero-aromatischen carbonaten WO2008052861A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ATA1687/2006 2006-10-10
AT16872006 2006-10-10

Publications (2)

Publication Number Publication Date
WO2008052861A2 WO2008052861A2 (de) 2008-05-08
WO2008052861A3 true WO2008052861A3 (de) 2008-09-12

Family

ID=39154003

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/060676 WO2008052861A2 (de) 2006-10-10 2007-10-09 Verfahren zur herstellung von 1,3 -hetero-aromatischen carbonaten

Country Status (1)

Country Link
WO (1) WO2008052861A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2354121B1 (de) 2010-02-05 2013-02-13 Philipps-Universität Marburg Hexaorganoguanidinium-organocarbonate, ihre Herstellung und ihre Verwendung
CN104090060B (zh) * 2014-07-28 2015-10-28 广州天赐高新材料股份有限公司 电解质锂盐中残留溶剂的检测方法
CN108368087B (zh) 2015-10-14 2022-04-12 百时美施贵宝公司 作为apj激动剂的2，4-二羟基-烟酰胺
UY37026A (es) 2015-12-16 2017-06-30 Bristol-Myers Squibb Company Una Corporación Del Estado De Delaware Heteroarilhidroxipirimidinonas como agonistas del receptor de apj
WO2017165640A1 (en) 2016-03-24 2017-09-28 Bristol-Myers Squibb Company 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
AU2017275657B2 (en) 2016-06-02 2021-08-19 Novartis Ag Potassium channel modulators
PL3571193T3 (pl) 2017-01-23 2022-04-25 Cadent Therapeutics, Inc. Modulatory kanału potasowego
KR20210080446A (ko) 2018-10-22 2021-06-30 카덴트 테라퓨틱스, 인크. 칼륨 채널 조절제의 결정 형태
CN114591245B (zh) * 2022-03-17 2024-04-05 浙江肯特催化材料科技有限公司 一种制备1,3-二烷基咪唑离子液体的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0291074A2 (de) * 1987-05-13 1988-11-17 Mitsubishi Petrochemical Co., Ltd. Verfahren zur Herstellung von quaternären Salzen
US5856513A (en) * 1996-07-04 1999-01-05 Mitsubishi Chemical Corporation Process for the preparation of N-alkyl-N'-methylimidazolinium salt of organic acid
DE19836477A1 (de) * 1998-08-12 2000-02-17 Basf Ag Verfahren zur Herstellung von 1,3-Dimethyl-imidazolium-4carboxylat

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0291074A2 (de) * 1987-05-13 1988-11-17 Mitsubishi Petrochemical Co., Ltd. Verfahren zur Herstellung von quaternären Salzen
US5856513A (en) * 1996-07-04 1999-01-05 Mitsubishi Chemical Corporation Process for the preparation of N-alkyl-N'-methylimidazolinium salt of organic acid
DE19836477A1 (de) * 1998-08-12 2000-02-17 Basf Ag Verfahren zur Herstellung von 1,3-Dimethyl-imidazolium-4carboxylat

Also Published As

Publication number Publication date
WO2008052861A2 (de) 2008-05-08

Similar Documents

Publication Publication Date Title
WO2008052861A3 (de) Verfahren zur herstellung von 1,3 -hetero-aromatischen carbonaten
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
WO2009079008A8 (en) Benzopyrans and analogs as rho kinase inhibitors
WO2009074875A8 (en) Sound-absorbing, resistant panels and process for making same
DE602005014936D1 (en) Phosphoramidatderivate
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
WO2008001101A3 (en) Pharmaceutical combinations
MX280092B (es) Proceso para producir un compuesto de 5 - hidroxi - 4 - tiometilpirazol.
UA101914C2 (en) Fungicidal composition
WO2008050140A3 (en) Compounds for treatment of parasitic infection
GB0521508D0 (en) Organic compounds
WO2007038678A8 (en) Analogs of ghrelin
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
MX2009008660A (es) Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos.
WO2009055289A3 (en) Therapeutic substituted lactams
RS20060297A (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
TW200612959A (en) Method for preparing hydroxamic acids
WO2008021975A3 (en) Therapeutic lactams
WO2008021346A3 (en) Pure paliperidone and processes for preparing thereof
TW200621756A (en) Method for manufacturing enantiomeric imidazole compounds
WO2006002073A3 (en) Method for preventing heme-induced lipid peroxidation
IN2014DN04588A (de)
WO2004092481A3 (de) Verfahren zur behandlung von papieroberflächen
WO2006118953A3 (en) Method of treating multiple myeloma using 17-aag of 17-ag of a prodrug of either
WO2008028032A3 (en) Therapeutic substituted hydantoins and related compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07821048

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07821048

Country of ref document: EP

Kind code of ref document: A2